Jian-Ying Zhang
Overview
Explore the profile of Jian-Ying Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
162
Citations
2310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ren P, Zhang J, Zhao L, Sun X
J Asian Nat Prod Res
. 2024 Dec;
:1-21.
PMID: 39671338
polyglycoside tablets (TWPT) have traditionally been used to treat certain inflammatory diseases. This study validated TWPT as a novel application in hepatocellular carcinoma treatment through multiple targets, thereby expanding its...
2.
Wang W, Zhao Z, Wang L, Li P, Chen K, Zhang J, et al.
EBioMedicine
. 2024 Apr;
103:105105.
PMID: 38579362
No abstract available.
3.
Wang W, Zhao Z, Wang L, Li P, Chen K, Zhang J, et al.
EBioMedicine
. 2024 Apr;
103:105106.
PMID: 38579361
No abstract available.
4.
Li J, Dai L, Huang M, Ma Y, Guo Z, Wang X, et al.
Oncoimmunology
. 2024 Jan;
10(1):1966969.
PMID: 38260036
Osteosarcoma (OS) is the most common highly malignant primary solid bone tumor. Despite its relatively low incidence among cancers, it remains one of the most harmful primary malignant tumors in...
5.
Qiu C, Wang X, Batson S, Wang B, Casiano C, Francia G, et al.
Cancers (Basel)
. 2023 Aug;
15(16).
PMID: 37627091
(1) Background: Autoantibodies to tumor-associated antigens (TAAs) have emerged as promising cancer biomarkers. Luminex technology offers a powerful approach for the simultaneous detection of multiple anti-TAA autoantibodies. (2) Methods: We...
6.
Qiu C, Ma Y, Wang B, Zhang X, Wang X, Zhang J
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36835134
Studies have demonstrated that autoantibodies to tumor-associated antigens (TAAs) may be used as efficient biomarkers with low-cost and highly sensitive characteristics. In this study, an enzyme-linked immunosorbent assay (ELISA) was...
7.
Zhang X, Xing M, Ma Y, Zhang Z, Qiu C, Wang X, et al.
Molecules
. 2023 Jan;
28(2).
PMID: 36677861
Esophageal squamous cell carcinoma is a severe malignancy for its high mortality and poor prognosis. Mainstay chemotherapies cause serious side effects for their ways of inducing cell death. Oridonin is...
8.
Ma Y, Qiu C, Wang B, Zhang X, Wang X, Aguilera R, et al.
Cells
. 2022 Oct;
11(20).
PMID: 36291095
Background: Tumor-associated antigens (TAAs) have been investigated for many years as potential early diagnosis tools, especially for hepatocellular carcinoma (HCC). Nonetheless, very few studies have focused on the Hispanic HCC...
9.
Wang L, Ji X, Wang L, Qiu J, Zhou F, Liu W, et al.
Front Cell Dev Biol
. 2022 Oct;
10:1008088.
PMID: 36211462
[This corrects the article DOI: 10.3389/fcell.2020.00840.].
10.
Yang X, Wang P, Ye H, Jiang M, Su Y, Peng X, et al.
Front Oncol
. 2022 Sep;
12:938234.
PMID: 36176418
Metabolomics has been reported as an efficient tool to screen biomarkers that are related to esophageal cancer. However, the metabolic biomarkers identifying malignant degrees and therapeutic efficacy are still largely...